Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
20-23 October, 2025
62nd Japanese Peptide62nd Japanese Peptide
Not Confirmed
Not Confirmed
21-23 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
20-23 October, 2025
62nd Japanese Peptide62nd Japanese Peptide
Industry Trade Show
Not Confirmed
21-23 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india
08 Apr 2023
// BIOSPECTRUM ASIA
https://www.biospectrumasia.com/news/30/22255/cepi-appoints-dr-yasuhiro-suzuki-to-the-board.html
27 Oct 2022
// PHARMACEUTICAL-TECHNOLOGY
https://www.pharmaceutical-technology.com/news/sk-bioscience-cepi-vaccine-deal/
26 Oct 2022
// INDIANPHARMAPOST
https://www.indianpharmapost.com/news/cepi-and-sk-bioscience-partner-to-advance-mrna-vaccine-technology-13207
06 Oct 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/cepi-partners-with-intravacc-to-develop-an-intranasal-broadly-protective-betacoronavirus-vaccine-301641943.html
05 Jul 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/07/05/2473809/0/en/CEPI-and-Codiak-BioSciences-partner-to-develop-broadly-protective-Betacoronavirus-vaccine.html
06 Apr 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/04/06/2418030/0/en/CEPI-to-co-fund-Vaxxinity-s-pivotal-Phase-3-UB-612-heterologous-booster-trial-to-combat-SARS-CoV-2-variants.html
ABOUT THIS PAGE